Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Mitotane changes steroid breakdown, affecting cortisol availability.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

A new therapy for a skin blistering condition has not been developed yet.

Notopterygii rhizoma et radix (Qiang Huo) can effectively treat psoriasis by reducing skin symptoms and inflammation.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Bempikibart may help regrow hair in people with alopecia areata.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.